Skip to content

Extrapulmonary Lung Protection Strategy for Patients With Mechanical Ventilation

Extrapulmonary Lung Protection Strategy for Patients With Mechanical Ventilation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03947476
Enrollment
100
Registered
2019-05-13
Start date
2019-08-01
Completion date
2021-08-01
Last updated
2019-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation, Transpulmonary Pressure, Ventilator-induced Lung Injury

Brief summary

As an important life sustaining support , mechanical ventilation has greatly promoted the development of modern intensive care units. However, mechanical ventilation can lead to ventilator-induced lung injury, including barotrauma, volutrauma, atelectrauma and biotrauma. All patients undergoing mechanical ventilation are at risk of barotrauma. A multicenter prospective cohort study of 5183 patients with mechanical ventilation showed that the incidence of pulmonary barotrauma was 3%. The incidence of pulmonary barotrauma varied according to the causes of mechanical ventilation: chronic obstructive pulmonary disease (3%), asthma (6%), chronic interstitial lung disease (10%), acute respiratory distress syndrome (7%) and pneumonia (4%). At present, it is considered that one of the main causes of barotrauma is the increasing of transpulmonary pressure. Transpulmonary pressure is the difference between alveolar pressure and intrapleural pressure. The commonly adopted lung protective ventilation methods include: limiting plateau pressure less than or equal to 30 cmH2O, using small tidal volume ventilation (6-8 mL/kg ideal body weight) . All the above methods are to reduce trans-pulmonary pressure by reducing alveolar pressure. In addition to reducing alveolar pressure, increasing pleural pressure is another important way to reduce transpulmonary pressure and the incidence of barotrauma. At present, the main method is the use of neuromuscular blockade. However, there are many shortcomings in of neuromuscular blockade: 1. Time limit, generally not more than 48 hours; 2. Long-term use of neuromuscular blockade causes adverse reactions such as myopathy; 3. Neuromuscular blockade are only suitable for invasive mechanical ventilation patients, but not for non-invasive mechanical ventilation or high flow oxygen inhalation patients. Therefore, it is urgent to find other methods to reduce trans-pulmonary pressure and lung injury. The investigators drew inspiration from the early mechanism of iron lung ventilator and the clinical practice of reducing trans-pulmonary pressure and lung injury in obese patients. In the early stage, the investigators carried out the clinical practice of extrapulmonary lung protection strategy, that is, to give thoracic band restraint to patients undergoing non-invasive mechanical ventilation so as to reduce chest wall compliance, which can be significantly reduced under the same inspiratory pressure and occurrence of barotrauma. However, the respiratory mechanics mechanism of this method still needs to be further studied to determine whether it can reduce the incidence of barotrauma by reducing transpulmonary pressure. It is accessible and inexpensive. The aim of this study was to determine the changes of transpulmonary pressure in patients with invasive mechanical ventilation before and after thoracic band fixation by esophageal manometry without spontaneous breathing.

Interventions

DEVICEthoracic band

Thoracic band fixation

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. BMI \> 18, BMI \< 40 2. Age \> 18 years old 3. Patients who need invasive mechanical ventilation for lower abdominal surgery, brain surgery, cerebral hemorrhage and cerebral infarction 4. Mechanical ventilation at least 12 hours

Exclusion criteria

1. BMI \< 18 or BMI \> 40 2. Age \< 18 years old 3. abstain from nasogastric tube 4. Pneumothorax 5. Pregnant women 6. Patients with severe hypoxemia

Design outcomes

Primary

MeasureTime frameDescription
Inspiratory of transpulmonary pressureup to 24 hoursMeasurement of transpulmonary pressure by placement of esophageal manometer tube during inspiratory,the metric is cmH2O
Expiratory of transpulmonary pressureup to 24 hoursMeasurement of transpulmonary pressure by placement of esophageal manometer tube during expiratory,the metric is cmH2O

Countries

China

Contacts

Primary ContactYimei Liu, master
liuyimei1988@163.com+8613916646834

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026